Longevity Surgeon: The Biomarkers That Predict If You'll Get Cancer or Alzheimer's

By The Longevity Surgeon | Updated 2024

We are witnessing the death of "reactive" medicine. For decades, doctors have waited for symptoms to appear—a lump in the breast, a forgotten name, a spike in blood sugar—before intervening. But the new frontier of longevity is predictive.

The "Longevity Surgeon" doesn't just fix what is broken; they look for the cracks in the foundation before the building collapses. Thanks to breakthroughs in liquid biopsies and neuro-imaging, we now have a crystal ball. But looking into it requires knowing which specific biomarkers to track.

The Surprising Truth: The same metabolic dysfunction that drives cancer often drives Alzheimer's. They are not separate diseases; they are often symptoms of the same systemic failure.

1. The Cancer Crystal Ball: ctDNA and IGF-1

Most people rely on annual physicals that check for existing masses. The cutting-edge approach looks for the ghosts of cancer before a tumor even forms.

The "Liquid Biopsy" (ctDNA)

Circulating Tumor DNA (ctDNA) is perhaps the most revolutionary biomarker of the decade. As cancer cells die, they shed fragments of their DNA into your bloodstream. New tests (like the Galleri test) can scan thousands of these fragments to detect cancer signals from over 50 types of cancer, often before symptoms arise.

"We are moving toward a world where a simple blood draw can tell us if a malignancy is brewing years before a scan could ever see it. This is the holy grail of early detection." — Dr. Peter Attia, Longevity Physician & Author of Outlive

The Growth Factor: IGF-1

Here is the surprising part: High levels of Insulin-like Growth Factor 1 (IGF-1) are strongly correlated with increased cancer risk. While IGF-1 is essential for muscle growth in youth, in mid-life, it acts as a fertilizer for potential cancer cells. Dr. Valter Longo's research suggests that keeping IGF-1 in a lower range through specific dietary protocols (like fasting-mimicking diets) can significantly reduce cancer incidence.

2. The Alzheimer's Early Warning System: NfL and ApoE4

Alzheimer's begins 20 years before memory loss. Waiting for cognitive decline is a failure of strategy. We must look at the biological wreckage occurring in the brain long before the patient forgets their keys.

Neurofilament Light Chain (NfL)

If you remember one biomarker from this article, let it be NfL. This protein is released into the blood and cerebrospinal fluid when neurons are damaged. Elevated NfL is a predictor of neurodegeneration across multiple diseases, including Alzheimer's, Parkinson's, and MS. It is the "check engine" light for your brain.

The Genetic Load: ApoE4

Having one copy of the ApoE4 allele increases Alzheimer's risk by 3x; two copies increase it by 12-15x. However, knowing your status is not a death sentence—it is a call to action. Dr. Dale Bredesen's protocol emphasizes that ApoE4 carriers must be hyper-vigilant about inflammation and insulin resistance.

3. The Common Thread: The Metabolic Link

Why do cancer and Alzheimer's often strike the same people? The answer lies in Metabolic Health.

Alzheimer's is increasingly being referred to as "Type 3 Diabetes." The brain becomes insulin resistant and cannot process glucose for fuel, leading to starvation of the neurons. Simultaneously, high insulin levels (hyperinsulinemia) drive cell proliferation, feeding cancer.

The Actionable Insight: You do not need to be diabetic to have metabolic dysfunction. A fasting insulin level that is "normal" by lab standards (e.g., 10-15 µIU/mL) may actually be too high for optimal longevity. The Longevity Surgeon aims for fasting insulin below 5 or 6 µIU/mL.

Frequently Asked Questions (FAQ)

Q: Can I test for these biomarkers at my regular doctor's office?

A: Not all of them. Standard blood panels check glucose and cholesterol, but rarely check fasting insulin, NfL, or ctDNA. You may need to seek out a functional medicine practitioner or a specialized longevity clinic to order these specific tests.

Q: If I have the ApoE4 gene, will I definitely get Alzheimer's?

A: Absolutely not. Genetics loads the gun, but lifestyle pulls the trigger. Many ApoE4 carriers live to 100 with sharp minds by strictly managing inflammation, sleep, and metabolic health.

Q: What is the most important lifestyle change to lower these risks?

A: Improving metabolic flexibility. This involves reducing refined carbohydrates, practicing intermittent fasting or time-restricted eating, and engaging in Zone 2 cardio exercise to improve mitochondrial efficiency.

#Longevity #Biomarkers #CancerPrevention #AlzheimersAwareness #MetabolicHealth #Biohacking #DrPeterAttia #LiquidBiopsy #NfL #IGF1

References & Further Reading

• Klein, E.A. et al. Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Nature (2021).
• Mattson, M.P. et al. Intermittent metabolic switching, neuroplasticity and brain health. Nature Reviews Neuroscience (2018).
• Brandhorst, S. et al. A Periodic Diet that Mimics Fasting Promotes Multi-System Regeneration... Cell Metabolism (2015).
• Alzforum: Neurofilament Light Chain (NfL) as a Blood Biomarker.

```